App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy

Launched by UNIVERSITY OF ERLANGEN-NÜRNBERG MEDICAL SCHOOL · Apr 11, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how to help patients with head and neck cancer maintain their nutrition during and after treatment with radiation or chemotherapy. It uses a smartphone app called Emento, which allows patients to record their diet and track their nutritional status. The goal is to reduce weight loss and prevent malnutrition, which can be common challenges for people undergoing these treatments.

To join the study, participants need to be at least 18 years old and diagnosed with squamous cell carcinoma in the head and neck area, and they must be receiving treatment after surgery or as a primary approach. They should also have a smartphone compatible with the Emento app. During the trial, patients will regularly update their nutritional information for eight weeks following their treatment. This study is currently recruiting participants, and it is open to people of all genders. If you or someone you know fits these criteria, this could be a valuable opportunity to receive support in managing nutrition during a challenging time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with squamous cell carcinoma in the head and neck region, who receive a postsurgical or definitive radio(chemo)therapy
• • Patients who have a smartphone on which the Emento app can be installed
• • Minimum age 18 years
• Exclusion Criteria:
• • Patients who are represented by a legal guardian
• • Patients who are not suitable for participation in the study due to a language barrier